APO RESEARCH · REPORT
Marine Omega-3
Marine Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of Marine Omega-3 involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Product & engineering
Understand the product.
Marine Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of Marine Omega-3 involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Selected research
Market Outlook & Growth Opportunities
Global Marine Omega-3 Market Outlook and Growth Opportunities 2026
Market perspective
Marine Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of Marine Omega-3 involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Global Marine Omega-3 key players include DSM, BASF, GC Rieber Oils, KD Pharma Group, Pelagia (EPAX), etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 55%, followed by South America, with a share about 20 percent. In terms of product, Marine Animals Source Omega-3 is the largest segment, with a share about 90%. And in terms of application, the largest application is Dietary Supplements, followed by Pet Foods, Fortified Food and Beverage, Infant Formula, Pharmaceuticals, etc.
This report provides an overview of the global Marine Omega-3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Marine Omega-3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Marine Omega-3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Marine Omega-3 market size, projected growth trends, production technologies, key applications, and end-use industries.
Marine Omega-3 Segment by Company
DSM
BASF
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma (Marine Ingredients)
GC Rieber
Polaris
Auqi
Kinomega
Skuny
Xinzhou
Anti-Cancer
Sinomega
Orkla Health
LYSI
OLVEA Fish Oils
Hofseth BioCare
Nippon Suisan Kaisha
Bioprocess Algae
Shandong Yuwang Pharmaceutical
Maruha Nichiro Foods
Solutex
Marine Omega-3 Segment by Type
Marine Animals Source Omega-3
Marine Plant Source Omega-3
Marine Omega-3 Segment by Application
Dietary Supplements
Fortified Food and Beverage
Infant Formula
Pharmaceuticals
Pet Foods
Others
Marine Omega-3 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Marine Omega-3 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Marine Omega-3 market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Marine Omega-3 significant trends, drivers, influence factors in global and regions.
6. To analyze Marine Omega-3 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Omega-3.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Marine Omega-3 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marine Omega-3 industry.
Chapter 3: Detailed analysis of Marine Omega-3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Marine Omega-3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Marine Omega-3 in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Animals Source Omega-3
- Marine Plant Source Omega-3
Applications
- Dietary Supplements
- Fortified Food and Beverage
- Infant Formula
- Pharmaceuticals
- Pet Foods
- Others
Companies covered
- DSM
- BASF
- EPAX
- Golden Omega
- TASA
- Omega Protein
- Croda
- KD Pharma (Marine Ingredients)
- GC Rieber
- Polaris
- Auqi
- Kinomega
- Skuny
- Xinzhou
- Anti-Cancer
- Sinomega
- Orkla Health
- LYSI
- OLVEA Fish Oils
- Hofseth BioCare
- Nippon Suisan Kaisha
- Bioprocess Algae
- Shandong Yuwang Pharmaceutical
- Maruha Nichiro Foods
- Solutex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Marine Omega-3 Sales Value (2021-2032)
- 1.2.2 Global Marine Omega-3 Sales Volume (2021-2032)
- 1.2.3 Global Marine Omega-3 Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Marine Omega-3 Market Dynamics
- 2.1 Marine Omega-3 Industry Trends
- 2.2 Marine Omega-3 Industry Drivers
- 2.3 Marine Omega-3 Industry Opportunities and Challenges
- 2.4 Marine Omega-3 Industry Restraints
3 Marine Omega-3 Market by Company
- 3.1 Global Marine Omega-3 Company Revenue Ranking in 2025
- 3.2 Global Marine Omega-3 Revenue by Company (2021-2026)
- 3.3 Global Marine Omega-3 Sales Volume by Company (2021-2026)
- 3.4 Global Marine Omega-3 Average Price by Company (2021-2026)
- 3.5 Global Marine Omega-3 Company Ranking (2024-2026)
- 3.6 Global Marine Omega-3 Company Manufacturing Base and Headquarters
- 3.7 Global Marine Omega-3 Company Product Type and Application
- 3.8 Global Marine Omega-3 Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Marine Omega-3 Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Marine Omega-3 Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Marine Omega-3 Market by Type
- 4.1 Marine Omega-3 Type Introduction
- 4.1.1 Marine Animals Source Omega-3
- 4.1.2 Marine Plant Source Omega-3
- 4.2 Global Marine Omega-3 Sales Volume by Type
- 4.2.1 Global Marine Omega-3 Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Marine Omega-3 Sales Volume by Type (2021-2032)
- 4.2.3 Global Marine Omega-3 Sales Volume Share by Type (2021-2032)
- 4.3 Global Marine Omega-3 Sales Value by Type
- 4.3.1 Global Marine Omega-3 Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Marine Omega-3 Sales Value by Type (2021-2032)
- 4.3.3 Global Marine Omega-3 Sales Value Share by Type (2021-2032)
5 Marine Omega-3 Market by Application
- 5.1 Marine Omega-3 Application Introduction
- 5.1.1 Dietary Supplements
- 5.1.2 Fortified Food and Beverage
- 5.1.3 Infant Formula
- 5.1.4 Pharmaceuticals
- 5.1.5 Pet Foods
- 5.1.6 Others
- 5.2 Global Marine Omega-3 Sales Volume by Application
- 5.2.1 Global Marine Omega-3 Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Marine Omega-3 Sales Volume by Application (2021-2032)
- 5.2.3 Global Marine Omega-3 Sales Volume Share by Application (2021-2032)
- 5.3 Global Marine Omega-3 Sales Value by Application
- 5.3.1 Global Marine Omega-3 Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Marine Omega-3 Sales Value by Application (2021-2032)
- 5.3.3 Global Marine Omega-3 Sales Value Share by Application (2021-2032)
6 Marine Omega-3 Regional Sales and Value Analysis
- 6.1 Global Marine Omega-3 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Marine Omega-3 Sales by Region (2021-2032)
- 6.2.1 Global Marine Omega-3 Sales by Region: 2021-2026
- 6.2.2 Global Marine Omega-3 Sales by Region (2027-2032)
- 6.3 Global Marine Omega-3 Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Marine Omega-3 Sales Value by Region (2021-2032)
- 6.4.1 Global Marine Omega-3 Sales Value by Region: 2021-2026
- 6.4.2 Global Marine Omega-3 Sales Value by Region (2027-2032)
- 6.5 Global Marine Omega-3 Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Marine Omega-3 Sales Value (2021-2032)
- 6.6.2 North America Marine Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Marine Omega-3 Sales Value (2021-2032)
- 6.7.2 Europe Marine Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Marine Omega-3 Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Marine Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Marine Omega-3 Sales Value (2021-2032)
- 6.9.2 South America Marine Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Marine Omega-3 Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Marine Omega-3 Sales Value Share by Country, 2025 VS 2032
7 Marine Omega-3 Country-level Sales and Value Analysis
- 7.1 Global Marine Omega-3 Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Marine Omega-3 Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Marine Omega-3 Sales by Country (2021-2032)
- 7.3.1 Global Marine Omega-3 Sales by Country (2021-2026)
- 7.3.2 Global Marine Omega-3 Sales by Country (2027-2032)
- 7.4 Global Marine Omega-3 Sales Value by Country (2021-2032)
- 7.4.1 Global Marine Omega-3 Sales Value by Country (2021-2026)
- 7.4.2 Global Marine Omega-3 Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.9.2 France Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.16.2 China Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.19.2 India Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Marine Omega-3 Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Marine Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Marine Omega-3 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 DSM
- 8.1.1 DSM Company Information
- 8.1.2 DSM Business Overview
- 8.1.3 DSM Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.1.4 DSM Marine Omega-3 Product Portfolio
- 8.1.5 DSM Recent Developments
- 8.2 BASF
- 8.2.1 BASF Company Information
- 8.2.2 BASF Business Overview
- 8.2.3 BASF Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.2.4 BASF Marine Omega-3 Product Portfolio
- 8.2.5 BASF Recent Developments
- 8.3 EPAX
- 8.3.1 EPAX Company Information
- 8.3.2 EPAX Business Overview
- 8.3.3 EPAX Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.3.4 EPAX Marine Omega-3 Product Portfolio
- 8.3.5 EPAX Recent Developments
- 8.4 Golden Omega
- 8.4.1 Golden Omega Company Information
- 8.4.2 Golden Omega Business Overview
- 8.4.3 Golden Omega Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Golden Omega Marine Omega-3 Product Portfolio
- 8.4.5 Golden Omega Recent Developments
- 8.5 TASA
- 8.5.1 TASA Company Information
- 8.5.2 TASA Business Overview
- 8.5.3 TASA Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.5.4 TASA Marine Omega-3 Product Portfolio
- 8.5.5 TASA Recent Developments
- 8.6 Omega Protein
- 8.6.1 Omega Protein Company Information
- 8.6.2 Omega Protein Business Overview
- 8.6.3 Omega Protein Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Omega Protein Marine Omega-3 Product Portfolio
- 8.6.5 Omega Protein Recent Developments
- 8.7 Croda
- 8.7.1 Croda Company Information
- 8.7.2 Croda Business Overview
- 8.7.3 Croda Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Croda Marine Omega-3 Product Portfolio
- 8.7.5 Croda Recent Developments
- 8.8 KD Pharma (Marine Ingredients)
- 8.8.1 KD Pharma (Marine Ingredients) Company Information
- 8.8.2 KD Pharma (Marine Ingredients) Business Overview
- 8.8.3 KD Pharma (Marine Ingredients) Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.8.4 KD Pharma (Marine Ingredients) Marine Omega-3 Product Portfolio
- 8.8.5 KD Pharma (Marine Ingredients) Recent Developments
- 8.9 GC Rieber
- 8.9.1 GC Rieber Company Information
- 8.9.2 GC Rieber Business Overview
- 8.9.3 GC Rieber Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.9.4 GC Rieber Marine Omega-3 Product Portfolio
- 8.9.5 GC Rieber Recent Developments
- 8.10 Polaris
- 8.10.1 Polaris Company Information
- 8.10.2 Polaris Business Overview
- 8.10.3 Polaris Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Polaris Marine Omega-3 Product Portfolio
- 8.10.5 Polaris Recent Developments
- 8.11 Auqi
- 8.11.1 Auqi Company Information
- 8.11.2 Auqi Business Overview
- 8.11.3 Auqi Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Auqi Marine Omega-3 Product Portfolio
- 8.11.5 Auqi Recent Developments
- 8.12 Kinomega
- 8.12.1 Kinomega Company Information
- 8.12.2 Kinomega Business Overview
- 8.12.3 Kinomega Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Kinomega Marine Omega-3 Product Portfolio
- 8.12.5 Kinomega Recent Developments
- 8.13 Skuny
- 8.13.1 Skuny Company Information
- 8.13.2 Skuny Business Overview
- 8.13.3 Skuny Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Skuny Marine Omega-3 Product Portfolio
- 8.13.5 Skuny Recent Developments
- 8.14 Xinzhou
- 8.14.1 Xinzhou Company Information
- 8.14.2 Xinzhou Business Overview
- 8.14.3 Xinzhou Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Xinzhou Marine Omega-3 Product Portfolio
- 8.14.5 Xinzhou Recent Developments
- 8.15 Anti-Cancer
- 8.15.1 Anti-Cancer Company Information
- 8.15.2 Anti-Cancer Business Overview
- 8.15.3 Anti-Cancer Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Anti-Cancer Marine Omega-3 Product Portfolio
- 8.15.5 Anti-Cancer Recent Developments
- 8.16 Sinomega
- 8.16.1 Sinomega Company Information
- 8.16.2 Sinomega Business Overview
- 8.16.3 Sinomega Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Sinomega Marine Omega-3 Product Portfolio
- 8.16.5 Sinomega Recent Developments
- 8.17 Orkla Health
- 8.17.1 Orkla Health Company Information
- 8.17.2 Orkla Health Business Overview
- 8.17.3 Orkla Health Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Orkla Health Marine Omega-3 Product Portfolio
- 8.17.5 Orkla Health Recent Developments
- 8.18 LYSI
- 8.18.1 LYSI Company Information
- 8.18.2 LYSI Business Overview
- 8.18.3 LYSI Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.18.4 LYSI Marine Omega-3 Product Portfolio
- 8.18.5 LYSI Recent Developments
- 8.19 OLVEA Fish Oils
- 8.19.1 OLVEA Fish Oils Company Information
- 8.19.2 OLVEA Fish Oils Business Overview
- 8.19.3 OLVEA Fish Oils Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.19.4 OLVEA Fish Oils Marine Omega-3 Product Portfolio
- 8.19.5 OLVEA Fish Oils Recent Developments
- 8.20 Hofseth BioCare
- 8.20.1 Hofseth BioCare Company Information
- 8.20.2 Hofseth BioCare Business Overview
- 8.20.3 Hofseth BioCare Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Hofseth BioCare Marine Omega-3 Product Portfolio
- 8.20.5 Hofseth BioCare Recent Developments
- 8.21 Nippon Suisan Kaisha
- 8.21.1 Nippon Suisan Kaisha Company Information
- 8.21.2 Nippon Suisan Kaisha Business Overview
- 8.21.3 Nippon Suisan Kaisha Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Nippon Suisan Kaisha Marine Omega-3 Product Portfolio
- 8.21.5 Nippon Suisan Kaisha Recent Developments
- 8.22 Bioprocess Algae
- 8.22.1 Bioprocess Algae Company Information
- 8.22.2 Bioprocess Algae Business Overview
- 8.22.3 Bioprocess Algae Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Bioprocess Algae Marine Omega-3 Product Portfolio
- 8.22.5 Bioprocess Algae Recent Developments
- 8.23 Shandong Yuwang Pharmaceutical
- 8.23.1 Shandong Yuwang Pharmaceutical Company Information
- 8.23.2 Shandong Yuwang Pharmaceutical Business Overview
- 8.23.3 Shandong Yuwang Pharmaceutical Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Shandong Yuwang Pharmaceutical Marine Omega-3 Product Portfolio
- 8.23.5 Shandong Yuwang Pharmaceutical Recent Developments
- 8.24 Maruha Nichiro Foods
- 8.24.1 Maruha Nichiro Foods Company Information
- 8.24.2 Maruha Nichiro Foods Business Overview
- 8.24.3 Maruha Nichiro Foods Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Maruha Nichiro Foods Marine Omega-3 Product Portfolio
- 8.24.5 Maruha Nichiro Foods Recent Developments
- 8.25 Solutex
- 8.25.1 Solutex Company Information
- 8.25.2 Solutex Business Overview
- 8.25.3 Solutex Marine Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.25.4 Solutex Marine Omega-3 Product Portfolio
- 8.25.5 Solutex Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Marine Omega-3 Value Chain Analysis
- 9.1.1 Marine Omega-3 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Marine Omega-3 Sales Mode & Process
- 9.2 Marine Omega-3 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Marine Omega-3 Distributors
- 9.2.3 Marine Omega-3 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst